Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

Published Date: 24 Oct 2026

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Published Date: 24 Oct 2026

Omid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.

Experts Examine Biologic Coverage in Asthma and COPD

Published Date: 24 Oct 2026

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Published Date: 24 Oct 2026

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Published Date: 24 Oct 2026

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

Published Date: 24 Oct 2026

Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

Published Date: 24 Oct 2026

The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.

Liposomal Mitoxantrone Shows Early Safety Signal in Phase 2 NMOSD Trial Marco Meglio

Published Date: 24 Oct 2026

A phase 2 trial found liposomal mitoxantrone hydrochloride had an acceptable safety profile and a potential trend toward fewer relapses in neuromyelitis optica spectrum disorder.

Robotics and Organ Preservation in Transplant, With Ari Cohen, MD Ari Cohen, MD, MBA

Published Date: 24 Oct 2026

An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.

Ochsner Health Expands Liver Transplant Access Through Multidisciplinary Care Ari Cohen, MD, MBA

Published Date: 24 Oct 2026

Ochsner Health uses multidisciplinary clinics, living donor programs, and transplant innovations to address access challenges.

Knowledge Hub

Oncology

Predicting Durable Response to Tumor-Directed Radiotherapy Through Clonal Repopulation Dynamics

Review of clonal repopulation dynamics as predictors of durable response to tumor-directed radiotherapy.

Oncology

Tumor-Associated Fibroblast Metabolites as Biomarkers of Stromal Activity

Evidence-based review on tumor-associated fibroblast metabolites as clinical biomarkers of stromal activity.

Oncology

Exposure-Response in Immuno-Oncology: Mechanisms, Clinical Insights, and Practical Implications

A comprehensive medical review on exposure-response in immuno-oncology, covering mechanisms, clinical insights, and practice implications.

Oncology

Circulating Metabolic Signatures of Tumor Nutrient Competition

Review of circulating metabolic signatures in tumor nutrient competition and their clinical implications for oncology.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

Liposomal Mitoxantrone Shows Early Safety Signal in Phase 2 NMOSD Trial Marco Meglio

Robotics and Organ Preservation in Transplant, With Ari Cohen, MD Ari Cohen, MD, MBA

Ochsner Health Expands Liver Transplant Access Through Multidisciplinary Care Ari Cohen, MD, MBA

Knowledge Hub

Predicting Durable Response to Tumor-Directed Radiotherapy Through Clonal Repopulation Dynamics

Tumor-Associated Fibroblast Metabolites as Biomarkers of Stromal Activity

Exposure-Response in Immuno-Oncology: Mechanisms, Clinical Insights, and Practical Implications

Circulating Metabolic Signatures of Tumor Nutrient Competition

Therapeutic Advances in Cancer-Associated Fibroblast Reprogramming

Strength Training During Cancer Recovery: Evidence-Based Clinical Insights

Assessing Therapy-Related Myeloid Neoplasm Risk Through Clonal Hematopoiesis and Treatment Exposure Integration

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

Liposomal Mitoxantrone Shows Early Safety Signal in Phase 2 NMOSD Trial Marco Meglio

Robotics and Organ Preservation in Transplant, With Ari Cohen, MD Ari Cohen, MD, MBA

Ochsner Health Expands Liver Transplant Access Through Multidisciplinary Care Ari Cohen, MD, MBA

Knowledge Hub

Predicting Durable Response to Tumor-Directed Radiotherapy Through Clonal Repopulation Dynamics

Tumor-Associated Fibroblast Metabolites as Biomarkers of Stromal Activity

Exposure-Response in Immuno-Oncology: Mechanisms, Clinical Insights, and Practical Implications

Circulating Metabolic Signatures of Tumor Nutrient Competition

Therapeutic Advances in Cancer-Associated Fibroblast Reprogramming

Strength Training During Cancer Recovery: Evidence-Based Clinical Insights

Assessing Therapy-Related Myeloid Neoplasm Risk Through Clonal Hematopoiesis and Treatment Exposure Integration

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views